Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
When They Should Not Be First-Line Therapy Despite their efficacy, novel weight loss peptides should generally not replace GLP-1 or GIP receptor agonists as initial therapy for uncomplicated obesity
These are given either in the muscle (intramuscularly) or under the skin (subcutaneously)
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat-diet-induced obesity in mice
Critical for energy, DNA repair, cellular health
Preclinical studies in diet-induced obesity models demonstrated 5-Amino-1MQ reduced body weight by 7% and increased energy expenditure by 9% over 11 days without dietary changes
US$ 21.32
US$ 25.76
US$ 28.23
US$ 26.16
US$ 24.91
US$ 22.59
US$ 27.47
US$ 20.30
US$ 28.64
US$ 20.94
